UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 133

Sortiert nach

Long-term treatment outcome should be prioritised in schizophrenia

European neuropsychopharmacology, 2016-10, Vol.26, p.S762-S762

Llorca, P.M

2016

Link zum Volltext

Verfügbarkeit prüfen

Psychopharmacology during residents’ training: The role of scientific societies

European psychiatry, 2016-03, Vol.33 (S1), p.S62-S62

Llorca, P.M

2016

Link zum Volltext

Verfügbarkeit prüfen

Quelle méthodologie pour l’évaluation de l’efficacité des antipsychotiques et quelles conséquences sur les recommandations professionnelles ?

European psychiatry, 2015-11, Vol.30 (8), p.S50-S50

Llorca, P.M

2015

Link zum Volltext

Verfügbarkeit prüfen

Risk factors for treatment resistance in unipolar depression: A systematic review

Journal of affective disorders, 2015-01, Vol.171, p.137-141

2015

Link zum Volltext

Verfügbarkeit prüfen

Metabolic syndrome, abdominal obesity and hyperuricemia in schizophrenia: Results from the FACE-SZ cohort

Schizophrenia research, 2015-10, Vol.168 (1), p.388-394

2015

Link zum Volltext

Verfügbarkeit prüfen

Childhood trauma, depression and negative symptoms are independently associated with impaired quality of life in schizophrenia. Results from the national FACE-SZ cohort

Schizophrenia research, 2017-07, Vol.185, p.173-181

2017

Link zum Volltext

Verfügbarkeit prüfen

Validation of a Psycho-Sensory hAllucinations Scale (PSAS) in schizophrenia and Parkinson's disease

Schizophrenia research, 2015-02, Vol.161 (2), p.269-276

2015

Link zum Volltext

Verfügbarkeit prüfen

Interest of clozapine and paliperidone palmitate plasma concentrations to monitor treatment in schizophrenic patients on chronic hemodialysis

Schizophrenia research, 2015-08, Vol.166 (1), p.351-352

2015

Link zum Volltext

Verfügbarkeit prüfen

An increase in joy after two weeks is more specific of later antidepressant response than a decrease in sadness

Journal of affective disorders, 2015-10, Vol.185, p.97-103

2015

Link zum Volltext

Verfügbarkeit prüfen

Akathisia: prevalence and risk factors in a community-dwelling sample of patients with schizophrenia. Results from the FACE-SZ dataset

Schizophrenia research, 2015-12, Vol.169 (1), p.255-261

2015

Link zum Volltext

Verfügbarkeit prüfen

C.12.03 Keeping the patient well: a new option to improve remission rate

European neuropsychopharmacology, 2010, Vol.20, p.S646-S647

Llorca, P.M

2010

Link zum Volltext

Verfügbarkeit prüfen

Peripheral sub-inflammation is associated with antidepressant consumption in schizophrenia. Results from the multi-center FACE-SZ data set

Journal of affective disorders, 2016-02, Vol.191, p.209-215

2016

Link zum Volltext

Verfügbarkeit prüfen

P.2.f.028 Course of anhedonia and depressive symptoms in a population of depressed outpatients treated with agomelatine

European neuropsychopharmacology, 2014-10, Vol.24, p.S468-S468

2014

Link zum Volltext

Verfügbarkeit prüfen

C.10.01 The newest results in schizophrenia research and treatment trends

European neuropsychopharmacology, 2019, Vol.29, p.S624-S625

Llorca, P.M.

2019

Link zum Volltext

Verfügbarkeit prüfen

Differential effects of childhood trauma and cannabis use disorders in patients suffering from schizophrenia

Schizophrenia research, 2016-08, Vol.175 (1-3), p.161-167

2016

Link zum Volltext

Verfügbarkeit prüfen

Predictors of rapid high weight gain in schizophrenia: Longitudinal analysis of the French FACE-SZ cohort

Journal of psychiatric research, 2017-11, Vol.94, p.62-69

2017

Link zum Volltext

Verfügbarkeit prüfen

Peripheral sub-inflammation is associated with antidepressant consumption in schizophrenia. Results from the multi-center FACE-SZ dataset

European psychiatry, 2016-03, Vol.33 (S1), p.S98-S98

2016

Link zum Volltext

Verfügbarkeit prüfen

Birth by cesarean section and schizophrenia. Results from the multi-center FACE-SZ dataset

European psychiatry, 2016-03, Vol.33 (S1), p.S98-S98

2016

Link zum Volltext

Verfügbarkeit prüfen

Abnormal C-reactive protein (CRP) levels in schizophrenia and schizoaffective disorders. Results from the FACE-SZ dataset

European psychiatry, 2015-11, Vol.30 (8), p.S112-S112

2015

Link zum Volltext

Verfügbarkeit prüfen

P.3.d.053 Beliefs toward antipsychotic medication in patients with schizophrenia: preliminary results

European neuropsychopharmacology, 2014-10, Vol.24, p.S553-S554

2014

Link zum Volltext

Verfügbarkeit prüfen

Punding in Parkinson's disease: To a better understanding of a common phenomenon between Parkinson's disease and addictions

European psychiatry, 2016-03, Vol.33 (S1), p.S145-S145

2016

Link zum Volltext

Verfügbarkeit prüfen

Psychose : l’importance du facteur migratoire

Encéphale, 2018-12, Vol.44 (6), p.S44-S46

Llorca, P.M.

2018

Link zum Volltext

Verfügbarkeit prüfen

C.04.03 - Long-term treatment outcome should be prioritised in schizophrenia

European neuropsychopharmacology, 2016-10, Vol.26, p.S762-S762

Llorca, P.M.

2016

Link zum Volltext

Verfügbarkeit prüfen

Metabolic syndrome, abdominal obesity and hyperuricemia in schizophrenia: Results from the FACE-SZ dataset

European psychiatry, 2015-11, Vol.30 (8), p.S130-S130

2015

Link zum Volltext

Verfügbarkeit prüfen

Medication and aggressiveness in real-world schizophrenia. Results from the FACE-SZ dataset

European psychiatry, 2015-11, Vol.30 (8), p.S153-S154

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 133

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(130)
Mit Volltextzugriff
(106)

Publikationsform

Artikel
(133)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Long-term treatment outcome should be prioritised in schizophrenia

Psychopharmacology during residents’ training: The role of scientific societies

Quelle méthodologie pour l’évaluation de l’efficacité des antipsychotiques et quelles conséquences sur les recommandations professionnelles ?

Risk factors for treatment resistance in unipolar depression: A systematic review

Metabolic syndrome, abdominal obesity and hyperuricemia in schizophrenia: Results from the FACE-SZ cohort

Childhood trauma, depression and negative symptoms are independently associated with impaired quality of life in schizophrenia. Results from the national FACE-SZ cohort

Validation of a Psycho-Sensory hAllucinations Scale (PSAS) in schizophrenia and Parkinson's disease

Interest of clozapine and paliperidone palmitate plasma concentrations to monitor treatment in schizophrenic patients on chronic hemodialysis

An increase in joy after two weeks is more specific of later antidepressant response than a decrease in sadness

Akathisia: prevalence and risk factors in a community-dwelling sample of patients with schizophrenia. Results from the FACE-SZ dataset

C.12.03 Keeping the patient well: a new option to improve remission rate

Peripheral sub-inflammation is associated with antidepressant consumption in schizophrenia. Results from the multi-center FACE-SZ data set

P.2.f.028 Course of anhedonia and depressive symptoms in a population of depressed outpatients treated with agomelatine

C.10.01 The newest results in schizophrenia research and treatment trends

Differential effects of childhood trauma and cannabis use disorders in patients suffering from schizophrenia

Predictors of rapid high weight gain in schizophrenia: Longitudinal analysis of the French FACE-SZ cohort

Peripheral sub-inflammation is associated with antidepressant consumption in schizophrenia. Results from the multi-center FACE-SZ dataset

Birth by cesarean section and schizophrenia. Results from the multi-center FACE-SZ dataset

Abnormal C-reactive protein (CRP) levels in schizophrenia and schizoaffective disorders. Results from the FACE-SZ dataset

P.3.d.053 Beliefs toward antipsychotic medication in patients with schizophrenia: preliminary results

Punding in Parkinson's disease: To a better understanding of a common phenomenon between Parkinson's disease and addictions

Psychose : l’importance du facteur migratoire

C.04.03 - Long-term treatment outcome should be prioritised in schizophrenia

Metabolic syndrome, abdominal obesity and hyperuricemia in schizophrenia: Results from the FACE-SZ dataset

Medication and aggressiveness in real-world schizophrenia. Results from the FACE-SZ dataset

Suchergebnisse filtern